Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Ortmeyer, H
Cost-effectiveness analysis indicates tirzepatide requires a 30% price reduction to meet standard thresholds, while semaglutide needs an 80% price cut from current levels
A systematic review found no acute toxicity in animals and no adverse events across various doses
The glycolysis modulator TIGAR, a fructose-2,6-bisphosphatase (Fru-2,6-BP), also plays a key role in the modulation of metabolism in response to oxidative stress
References Lee YS, Jun HS
US$ 20.33
US$ 28.95
US$ 23.44
US$ 28.65
